• Increase chance of regulatory approval of your drug development plans
• Substantially reduce project risks
• Delegate procedural work

Do you want to increase the likelihood that authorities are in line with your clinical trial plans and accept your data? One of the best ways is meeting the authorities to obtain their scientific advice. Lumis is curious to learn about your investigational product and can support you in communicating with authorities, procedural work, and briefing document preparation. We are familiar with the needs and culture of small companies and know how to prepare, organise, conduct and follow-up on Scientific Advice meetings with national authorities and European Medicines Agency (EMA). We help you prepare the needed documents and guide you through an efficient process for regulatory acceptance.

Are you looking for EMA incentives to substantially reduce costs of regulatory fees? Lumis offers procedural support to register your company as a small or medium-sized enterprise (SME). You can also rely on us for applying for orphan designation at EMA for product developed in rare diseases and to take advantage of the incentives provided by the EMA. Our experts provide full support to formally apply for the orphan designation and coordinates the meetings with the EMA.